Michiko Ono Selected Research

SB-656104-A

5/2013

The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michiko Ono Research Topics

Disease

3	Schizophrenia (Dementia Praecox) 03/2015 - 05/2013
1	Inflammation (Inflammations) 01/2019
1	Memory Disorders (Memory Loss) 05/2013

Drug/Important Bio-Agent (IBA)

1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	MineralsIBA 01/2019
1	Dopamine D3 ReceptorsIBA 03/2015
1	tandospironeIBA 01/2015
1	blonanserinIBA 01/2015
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2015
1	5-HT1A Serotonin ReceptorIBA 01/2015
1	Haloperidol (Haldol)FDA LinkGeneric 01/2015
1	Antipsychotic Agents (Antipsychotics)IBA 05/2013
1	Dizocilpine Maleate (Dizocilpine)IBA 05/2013
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2013
1	Lurasidone Hydrochloride FDA Link 05/2013
1	SB-656104-AIBA 05/2013
1	serotonin 7 receptorIBA 05/2013
1	N-Methylaspartate (NMDA)IBA 05/2013

Therapy/Procedure

1	Renal Dialysis (Hemodialysis) 01/2019
1	Therapeutics 01/2015